(Q82895095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

What's fueling the biotech engine--2010 to 2011 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Saurabh Aggarwal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

8 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1083-1089

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt.2060

18 January 2020

exact match

0 references

cites work

Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.

1 reference

12 December 2020

Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study

1 reference

12 December 2020

Systemic lupus erythematosus in the elderly

1 reference

12 December 2020

Targeted cancer therapies

1 reference

12 December 2020

Response-guided telaprevir combination treatment for hepatitis C virus infection

1 reference

12 December 2020

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

What's fueling the biotech engine?

1 reference

12 December 2020

What's fueling the biotech engine-2009-2010

1 reference

12 December 2020

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

12 December 2020

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

1 reference

12 December 2020

Telaprevir for previously untreated chronic hepatitis C virus infection

1 reference

12 December 2020

The 2009 COID recommendations for RSV prophylaxis: issues of efficacy, cost, and evidence-based medicine

1 reference

12 December 2020

What's fueling the biotech engine--2008

1 reference

12 December 2020

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

1 reference

12 December 2020

Developing the nation's biosimilars program

1 reference

12 December 2020

What's fueling the biotech engine-2007.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NBT.2060

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22158359%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference